GENERIC NAME OF THE MEDICINAL PRODUCT:
Valsartan Tablets USP 80mg
Valsartan Tablets USP 160mg
Valsartan Tablets USP 320mg
QUALITATIVE AND QUANTITATIVE COMPOSITION:
Each film coated tablets contains:
Valsartan USP…………………….…40mg
Excipients………………………………………q.s.
colures: Iron Oxide Yellow
b) Valsartan Tablets USP 80mg Each film coated tablets contains:
Valsartan USP………………….80mg
Excipients……………………………………. q.s.
colures: Red Oxide iron
c) Valsartan Tablets USP 160mg
Each film coated tablets contains:
Valsartan USP…………………….…160mg
Excipients………………………………………q.s.
colures: Iron Oxide Yellow
d) Valsartan Tablets USP 320mg
Each film coated tablets contains:
Valsartan USP……………………….320mg
Excipients…………………………………………. q.s.
colures: F&D Blue (Indigo Carmine).
THERAPEUTIC INDICATIONS:
Valsartan fixed-dose combination is indicated in patients whose blood pressure is not adequately controlled on valsartan monotherapy.
CAUTION & WARNING:
Read enclosed leaflet before use.
KEEP MEDICINE OUT OF REACH OF CHILDREN.
SWALLOW WHOLE DO NOT CHEW OR CRUSH
WARNING: To be sold by retail on the prescription of a Registered Medical Practitioner only.
STORAGE & DOSAGE:
Dosage: As directed by the Physician.
Attach dispensing label as per end county.
Valsartan Tablets USP Technical Specification:
| Product Name: |
Valsartan Tablets USP |
| Brand Name: | Generics |
| Strength: | 40mg, 80mg, 160mg, 320mg |
| Dosage Form: | Tablets (Film-coated) |
| Route of Administration: | Via oral Route |
| Packing: | 30s, 90s, 100s, 500s, 1000s |
| Pack Insert/Leaflet: | PIL (Patient Information Leaflet), SmPC (Summary Product Characteristics) |
| Regulatory Documents: | COA, MOA, COPP, FSC, Stability Studies, GMP, CTD Dossier |
| Therapeutic use: | Anti-hypertensive, Diuretics, Enzyme Inhibitor, Cardiovascular System. |
| Indication: | Valsartan is indicated for the treatment of hypertension, to lower blood pressure. |
| Storage: | Protect form moisture at a temperature not exceeding 30˚C.Do not freeze. Keep the container tightly closed in order to protect from moisture. |
GENERIC NAME OF THE MEDICINAL PRODUCT:
- Valsartan Tablets USP 40mg
- Valsartan Tablets USP 80mg
- Valsartan Tablets USP 160mg
- Valsartan Tablets USP 320mg
QUALITATIVE AND QUANTITATIVE COMPOSITION:
a) Valsartan Tablets USP 40mg
Each film coated tablets contains:
Valsartan USP…………………….…40mg
Excipients………………………………………q.s.
Colures: Iron Oxide Yellow
b) Valsartan Tablets USP 80mg
Each film coated tablets contains:
Valsartan USP………………….80mg
Excipients……………………………………. q.s.
colures: Red Oxide iron
c) Valsartan Tablets USP 160mg
Each film coated tablets contains:
Valsartan USP…………………….…160mg
Excipients………………………………………q.s.
colures: Iron Oxide Yellow
d) Valsartan Tablets USP 320mg
Each film coated tablets contains:
Valsartan USP……………………….320mg
Excipients…………………………………………. q.s.
colures: F&D Blue (Indigo Carmine).
THERAPEUTIC INDICATIONS:
- Treatment of essential hypertension in adults. Valsartan fixed-dose combination is indicated in patients whose blood pressure is not adequately controlled on valsartan monotherapy.
CAUTION & WARNING:
- CAUTION:
Read enclosed leaflet before use.
Keep medicine out of reach of children.
SWALLOW WHOLE DO NOT CHEW OR CRUSH - Warning: To be sold by retail on the prescription of a Registered Medical Practitioner only.
STORAGE & DOSAGE:
- Storage: Protect form moisture at a temperature not exceeding 30˚C. Do not freeze. Keep the container tightly closed in order to protect from moisture.
- Dosage: As directed by the Physician.
| Attach dispensing label as per end county. |






